Characteristic | Median (IQR) | p valuea | ||||||
---|---|---|---|---|---|---|---|---|
AD (n = 73) | MCI (n = 32) | SCI (n = 12) | NDD (n = 31) | OND (n = 36) | AD vs. MCI/SCI | AD vs. NDD/OND | NAs | |
APOE ε4, No. (%) | 24 (33)b | 9 (28) | 0 (0) | 4 (13) | 4 (11) | 0.045 | 0.014 | |
Female, no. (%) | 36 (49) | 16 (50) | 7 (58) | 10 (32) | 19 (53) | 0.89 | 0.20 | |
Age, y | 71 (68–76) | 69 (64–77) | 69 (62–72) | 70 (66–77) | 54 (35–67)c | 0.50 | < 0.001 | |
Education, y | 9 (5–12) | 9 (6–12) | 14 (10–15) | 9 (5–15) | 11 (10–14) | 0.20 | 0.47 | 3 | 1 | 3 | 1 | 26 |
MMSE, /30 | 24 (20–26)d | 27 (26–29) | 29 (27–30) | 23 (19–28) | 23 (17–27) | < 0.001 | 0.99 | 6 | 1 | 0 | 4 | 26 |
CSF, pg/ml | ||||||||
Aβ42 | 578 (486–703)e | 885 (609–1205) | 800 (689–1477) | 738 (590–1049) | 971 (736–1206) | < 0.001 | < 0.001 | 3 | 4 | 4 | 0 | 19 |
Aβ42/40 | 0.034 (0.027–0.045)e | 0.065 (0.047–0.078) | 0.062 (0.051–0 .072) | 0.083 (0.055–0.096) | 0.086 (0.048–0.097) | < 0.001 | < 0.001 | 33 | 9 | 7 | 12 | 22 |
p-tau181 | 82 (66–106)e | 45 (34–60) | 41 (39–42) | 33 (26–53) | 33 (26–42) | < 0.001 | < 0.001 | 3 |4 | 4 | 0 | 19 |
t-tau | 630 (503–840)e | 276 (229–391) | 221 (200–228) | 226 (170–388) | 220 (144–340) | < 0.001 | < 0.001 | 3 | 4 | 4 | 0 | 19 |